How much does Theranos' power-packed board help it navigate D.C.?
Lab testing company Theranos Inc. has done amazing things over the past couple of years, not the least of which was last week's win of a key bureaucratic waiver from the FDA.
The waiver from CLIA — the Clinical Laboratory Improvements Act — is for a herpes simplex 1 test developed by the Palo Alto company It which was started 12 years ago by then-19-year-old Stanford University dropout Elizabeth Holmes and came out of stealth two years ago. More important, though, the Food and Drug Administration… (Source: bizjournals.com Health Care:Hospitals headlines)
Source: bizjournals.com Health Care:Hospitals headlines - July 20, 2015 Category: Hospital Management Authors: Ron Leuty Source Type: news
How much does Theranos' power-packed board help it navigate D.C.?
Lab testing company Theranos Inc. has done amazing things over the past couple of years, not the least of which was last week's win of a key bureaucratic waiver from the FDA.
The waiver from CLIA — the Clinical Laboratory Improvements Act — is for a herpes simplex 1 test developed by the Palo Alto company, which was started 12 years ago by then-19-year-old Stanford University dropout Elizabeth Holmes and came out of stealth two years ago. More importantly, though, the Food and Drug Administration… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 20, 2015 Category: Biotechnology Authors: Ron Leuty Source Type: news
How much does Theranos' power-packed board help it navigate D.C.?
Lab testing company Theranos Inc. has done amazing things over the past couple of years, not the least of which was last week's win of a key bureaucratic waiver from the FDA.
The waiver from CLIA — the Clinical Laboratory Improvements Act — is for a herpes simplex 1 test developed by the Palo Alto company, which was started 12 years ago by then-19-year-old Stanford University dropout Elizabeth Holmes and came out of stealth two years ago. More importantly, though, the Food and Drug Administration… (Source: bizjournals.com Health Care:Hospitals headlines)
Source: bizjournals.com Health Care:Hospitals headlines - July 20, 2015 Category: Hospital Management Authors: Ron Leuty Source Type: news
Theranos secures FDA waiver to take its blood tests out of the lab
Palo Alto-based novel blood test company Theranos was granted a waiver from the FDA allowing the company to offer its first FDA-cleared blood test, its herpes simplex 1 virus IgG (HSV IgG) test, outside of a lab setting. According to the company, it’s the first HSV test to receive the waiver, called a CLIA waiver (CLIA stands […] (Source: mobihealthnews)
Source: mobihealthnews - July 20, 2015 Category: Information Technology Authors: Jonah Comstock Tags: Government/Regulation blood tests CLIA waiver herpes HSV mobile lab tests Theranos Source Type: news
Blood Tests Could Soon Be As Easy As A Trip To Walgreens
A little-known healthcare start-up is slowly setting the stage to transform blood tests.
Theranos, a Palo Alto, Calif.-based company that offers about 153 tests for under $10, scored two major coups in the past week. First, they won FDA approval for their patented technology that performs complex medical tests using just a few drops, rather than a few vials, of blood. It's first application, named in the FDA announcement, extends to the company’s herpes simplex 1 test.
While FDA approval isn't necessary to operate, the decision validates the result of Theranos founder, Elizabeth Holmes' decade-long research, which ai...
Source: Healthy Living - The Huffington Post - July 8, 2015 Category: Consumer Health News Source Type: news
Theranos gets unnecessary FDA clearance for its cheap, fingerstick blood tests
Theranos, the 12-year-old Palo Alto-based company working on a smaller, cheaper, alternative to common lab blood tests, has received its first voluntary FDA 510(k) clearance, for its herpes simplex 1 virus IgG (HSV IgG) test. Using a (still largely secretive) lab-on-a-chip technology, Theranos is able to run multiple blood tests on just a few drops of blood, whereas traditional […] (Source: mobihealthnews)
Source: mobihealthnews - July 6, 2015 Category: Information Technology Authors: Jonah Comstock Tags: Consumer Government/Regulation blood tests FDA FDA 510(k) FDA clearance lab on a chip Theranos Theranos Android app Theranos app Theranos iPhone app Source Type: news
Herpes Virus Tied to Angina Risk
But researchers note that only 1 percent of people has the virus strain hidden in their DNA
Source: HealthDay
Related MedlinePlus Pages: Angina, Herpes Simplex (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 17, 2015 Category: Consumer Health News Source Type: news
New blood test for viral infections shows promise
Conclusion
This research has developed a test that is able to identify past viral infections using a small sample of blood, giving an insight into a person's history of viral infections. The test could theoretically be expanded to cover other types of organisms that cause human disease, such as bacteria.
No test is perfect, however, and there were some cases where a known infection was not identified (false negative) and where an infection was picked up that was not thought to have really occurred (false positive). The test detects antibodies generated in response to viruses as the result of vaccination.
Antibody response...
Source: NHS News Feed - June 8, 2015 Category: Consumer Health News Tags: Medical practice Source Type: news
Injectable T-VEC Offers Hope to Melanoma PatientsInjectable T-VEC Offers Hope to Melanoma Patients
A dual-mechanism immunotherapy based on a genetically modified version of the herpes simplex virus achieves a durable response in melanoma patients. Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 28, 2015 Category: Dermatology Tags: Hematology-Oncology News Source Type: news
Modified herpes virus 'could combat skin cancer'
Conclusion
This randomised controlled trial has demonstrated the effectiveness of a novel injectable immune treatment for advanced melanoma that cannot be surgically removed.
The trial has various strengths, including its large sample size, analysis by intention to treat, and blinding of assessors to treatment assignment, which should have reduced the risk of bias.
It demonstrated that, overall, significantly more people responded to treatment with T-VEC than GM-CSF injections. It also improved survival by an average of 4.4 months, but this only just reached statistical significance, meaning we can have less confidence i...
Source: NHS News Feed - May 27, 2015 Category: Consumer Health News Tags: Cancer Medication Medical practice Source Type: news
Cold sore virus 'treats skin cancer'
A genetically engineered version of a virus that normally causes cold sores shows real promise for treating skin cancer, say researchers. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 26, 2015 Category: Consumer Health News Source Type: news
PAS: Use high-dose acyclovir to treat HSV-infected infants
SAN DIEGO – Infants given high-dose acyclovir for the treatment of herpes simplex virus (HSV) infections experienced a number of adverse reactions, including seizure, hypotension, and thrombocytopenia, according to the results of a new study, but it is unclear if the root cause of these events is... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 21, 2015 Category: Dermatology Tags: FPN Conferences PED Conferences SAN Conference News FPN News FPN Child & Adolescent Medicine FPN Dermatology FPN Infectious Diseases PED News Source Type: news
Many Americans Under 50 Living with Cold Sore Virus
American Academy of Dermatology offers advice for treating and preventing spread
Source: HealthDay
Related MedlinePlus Page: Cold Sores (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 9, 2015 Category: Consumer Health News Source Type: news
Wayne State researchers seek to stamp out herpes simplex virus 1
(Wayne State University - Office of the Vice President for Research) Wayne State University has received a $1.8 million grant from the National Institutes of Health to garner more genomic information about herpes simplex virus 1 with the hope of developing the cellular defense mechanisms of host defenses that could lead to new anti-herpes treatments. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 5, 2015 Category: Biology Source Type: news
Lesbians Receiving Unequal Treatment from Cuban Health Services
Two women hugging at a Day Against Homophobia in Havana organised by the lesbian, gay, bisexual and transsexual (LGBT) community. Credit: Jorge Luis Baños/IPSBy Ivet GonzálezHAVANA, Apr 1 2015 (IPS)In addition to other forms of discrimination, lesbian and bisexual women in Cuba face unequal treatment from public health services. Their specific sexual and reproductive health needs are ignored, and they are invisible in prevention and treatment campaigns for women.Many lesbian and bisexual women are afraid of gynaecological instruments and procedures which they experience as particularly distasteful given their sexual orie...
Source: IPS Inter Press Service - Health - April 1, 2015 Category: Global & Universal Authors: Ivet Gonzalez Tags: Active Citizens Civil Society Development & Aid Editors' Choice Gender Headlines Health Human Rights Latin America & the Caribbean LGBTQ Population Poverty & MDGs Regional Categories Women's Health Cuba National Centre for Se Source Type: news
